Relapsed/refractory patients

Assoc. Prof. Jonathan Kaufman | ASH 2017 | Venetoclax as targeted therapy for t(11:14) RRMM Patients

L:

59th ASH Annual Meeting and Exposition, 9 - 12 Dec 2017, Atlanta, GA

Associate Professor Jonathan Kaufman

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF